These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6114930)
41. Pharmacokinetics of oxprenolol in normal subjects. Mason WD; Winer N Clin Pharmacol Ther; 1976 Oct; 20(4):401-12. PubMed ID: 10124 [TBL] [Abstract][Full Text] [Related]
42. Plasma concentration and antihypertensive effect of beta-receptor blockers. Hitzenberger G Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485 [No Abstract] [Full Text] [Related]
43. Beta-adrenoceptor blockers and the blood-brian barrier. Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665 [TBL] [Abstract][Full Text] [Related]
44. Interaction of cimetidine with metoprolol, propranolol, or atenolol. Kirch W; Köhler H; Spahn H; Mutschler E Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283 [No Abstract] [Full Text] [Related]
45. Pharmacokinetics of beta-receptor-blocking agents in relation to their anti-hypertensive effect. Gugler R; Bodem G; Dengler HJ Clin Sci Mol Med Suppl; 1976 Dec; 3():473s-475s. PubMed ID: 15758 [TBL] [Abstract][Full Text] [Related]
46. Propranolol and metoprolol: Two comparable drugs with very different post-mortem toxicological profiles. Kriikku P; Pelkonen S; Kaukonen M; Ojanperä I Forensic Sci Int; 2021 Oct; 327():110978. PubMed ID: 34481114 [TBL] [Abstract][Full Text] [Related]
47. Influence of continuous ambulatory peritoneal dialysis on serum alpha 1-acid glycoprotein concentration and drug binding. Belpaire FM; Van de Velde EJ; Fraeyman NH; Bogaert MG; Lameire N Eur J Clin Pharmacol; 1988; 35(4):339-43. PubMed ID: 3197741 [TBL] [Abstract][Full Text] [Related]
48. [Comparative study of various beta-adrenergic blockers in clinical anesthesiology--alprenolol, oxprenolol, propranolol and LB-46]. Miyazaki M; Fujita T Masui; 1972 Jan; 21(1):1-10. PubMed ID: 4401934 [No Abstract] [Full Text] [Related]
49. Absence of DNA damage in mice and rats given high doses of five beta-adrenergic blocking agents. Maura A; Carlo P; Ricci R; Cavanna M; Brambilla G Arzneimittelforschung; 1985; 35(8):1236-8. PubMed ID: 2866775 [TBL] [Abstract][Full Text] [Related]
50. Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales. Lewis RV; Jackson PR; Ramsay LE Br J Clin Pharmacol; 1985 Feb; 19(2):255-7. PubMed ID: 2859044 [TBL] [Abstract][Full Text] [Related]
51. Enhancement of the bioavailability of propranolol and metoprolol by food. Melander A; Danielson K; Scherstén B; Wåhlin E Clin Pharmacol Ther; 1977 Jul; 22(1):108-12. PubMed ID: 872491 [TBL] [Abstract][Full Text] [Related]
52. A method for the assay of alpha 1-acid glycoprotein in dog serum and its application to the plasma binding of propranolol and oxprenolol in animals receiving rifampicin. Delcroix C; Fraeyman N; Belpaire F J Pharmacol Methods; 1984 Sep; 12(2):97-105. PubMed ID: 6536820 [TBL] [Abstract][Full Text] [Related]
53. Exercise increases plasma concentrations of (R)- and (S)-propranolol. Stoschitzky K; Schumacher M; Stark G; Dimai HP; Stauber R; Stoschitzky P; Krejs GJ; Klein W; Lindner W Eur J Clin Pharmacol; 1996; 50(4):339-42. PubMed ID: 8803530 [TBL] [Abstract][Full Text] [Related]
54. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. Frishman W; Jacob H; Eisenberg E; Ribner H Am Heart J; 1979 Dec; 98(6):798-811. PubMed ID: 40429 [No Abstract] [Full Text] [Related]